Glass House Brands Inc

Aktienanalyse zu Glass House Brands Inc (GLAS)

$3.190

-0.447 (-14.02%)Zum Schluss

Loading chart…
Hoch
3.835
Eröffnung
3.740
Volumengewichteter Durchschnittskurs
3.38
Volumen
2.03M
Marktkap.
—
Tief
3.100
Umsatz
6.86M
EV/EBITDA, TTM
-1,764.30

Glass House Brands Inc. is a vertically integrated cannabis company. The Company, through its subsidiaries, cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and cannabis-related consumer packaged goods (CPG) to third-party retail stores in the state of California. The Company also owns and operates retail cannabis stores in the state of California. The Company operates in three reportable segments: retail, wholesale biomass and cannabis-related consumer packaged goods (CPG). The Company operates multiple greenhouse cultivation facilities located in Carpinteria and Camarillo, California, and its manufacturing production facility is located in Lompoc, California. Its portfolio of brands includes Glass House Farms, PLUS, REEFORM, Allswell, and Mama Sue Wellness. Its retail landscape consists of approximately 10 stores positioned across California, including the pottery, farmacy, and natural healing center (NHC).

KI-Analyse of Glass House Brands Inc (GLAS)

Verkaufen

Given the current price of $3.19, the stock has seen a significant decline of 74.68% year-to-date. The RSI is extremely low at 3.639, indicating oversold conditions, but the forward P/E ratio is high at 31.4465, suggesting that the stock may be overvalued relative to its earnings potential. The gross margin has also dropped to 26.22%, down from 46.81% in the previous year, highlighting deteriorating profitability. While there is potential for recovery, the risks associated with persistent net losses and high reliance on external capital make this a sell for now.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Glass House Brands Inc (GLAS) beträgt 31.45, verglichen mit dem 5-Jahres-Durchschnitt von 168.99.

Erwartetes KGV

Unterbewertet
5J-Durchschnitt P/E
168.99
Aktuelles P/E
31.45
Überbewertet
281.81
Unterbewertet
56.18

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
-2219.85
Aktuelles EV/EBITDA
-1764.30
Überbewertet
440.31
Unterbewertet
-4880.01

Erwartetes KUV

Stark unterbewertet
5J-Durchschnitt P/S
3.13
Aktuelles P/S
1.39
Überbewertet
3.82
Unterbewertet
2.44

Event-Zeitleiste

2026-10-19 (ET)

08:00:00

Glass House Sets FY26 Production Cost Target at $95

08:00:00

Glass House Reports Record Biomass Production of 317,000 Pounds in Q3

2026-10-14 (ET)

08:00:00

Glass House Achieves GACP Certification, Aiming for Medical Cannabis Exports

2026-09-29 (ET)

08:00:00

Glass House Brands CFO Mark Vendetti Plans Retirement

2026-08-13 (ET)

17:00:00

Company Reports Q2 Adjusted EBITDA of $5.7M

News

GLAS FAQ – beantwortet von Alphio AI

Glass House Brands Inc. is a vertically integrated cannabis company. The Company, through its subsidiaries, cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and cannabis-related consumer packaged goods (CPG) to third-party retail stores in the state of California. The Company also owns and operates retail cannabis stores in the state of California. The Company operates in three reportable segments: retail, wholesale biomass and cannabis-related consumer packaged goods (CPG). The Company operates multiple greenhouse cultivation facilities located in Carpinteria and Camarillo, California, and its manufacturing production facility is located in Lompoc, California. Its portfolio of brands includes Glass House Farms, PLUS, REEFORM, Allswell, and Mama Sue Wellness. Its retail landscape consists of approximately 10 stores positioned across California, including the pottery, farmacy, and natural healing center (NHC). It operates in the Consumer Non-Cyclicals sector.

Given the current price of $3.19, the stock has seen a significant decline of 74.68% year-to-date. The RSI is extremely low at 3.639, indicating oversold conditions, but the forward P/E ratio is high at 31.4465, suggesting that the stock may be overvalued relative to its earnings potential. The gross margin has also dropped to 26.22%, down from 46.81% in the previous year, highlighting deteriorating profitability. While there is potential for recovery, the risks associated with persistent net losses and high reliance on external capital make this a sell for now.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln